The objective of this proposal is to develop novel approaches for efficient hepatocyte-directed delivery of nucleic acids. The proposal is based on our previous work demonstrating that DNA can be targeted specifically to hepatocytes using a DNA carrier containing an asialoglycoprotein that is recognized by receptors on the plasma membrane of hepatocytes. We will test the major hypothesis that natural proteins and peptide components can be incorporated into complexes to enhance intracellular delivery of DNA and expression of genes targeted to hepatocytes. The project proposes to use a modular design for the preparation of conjugates for DNA delivery. With this strategy, separate conjugates will be prepared which incorporate empty parvoviral capsids, individual capsid proteins, and a bacterial protein listeriolysin O, as endosomolytic agents to promote escape of targeted DNA from endosomal vesicles into the cytoplasm following internalization. Nuclear targeting sequences derived from SV-40 T-antigen will be incorporated into conjugates to direct efficient migration of DNA to the nucleus following escape from endosomes. These modules will be assessed first individually, and then in combination. In this way, optimal systems will be developed to deliver DNA in the form of genes to produce new gene expression. In addition to DNA as genes, antisense oligonucleotides will be delivered to inhibit endogenous gene expression. Pharmacological and genetic approaches to prolong the duration of targeted gene expression will be explored. Conditions that increase the likelihood of integration of the foreign genes into the host genome will be tested. The modular systems and protocols will be tested for efficiency and duration of effects on gene expression in vitro and in vivo. Finally, the function of the DNA targeted as optimal modular complexes will be evaluated in animal models of genetic disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042182-09
Application #
2734088
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Doo, Edward
Project Start
1990-01-01
Project End
2000-06-30
Budget Start
1998-08-01
Budget End
2000-06-30
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Connecticut
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Farmington
State
CT
Country
United States
Zip Code
06030
Smolic, Martina; Wu, Catherine H; Madadi, Shilpa et al. (2012) Pharmacogenetic selection of transplanted human hepatocytes in immunocompetent rats. J Dig Dis 13:579-87
Smolic, Robert; Smolic, Martina; Andorfer, John H et al. (2010) Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics. World J Gastroenterol 16:2100-8
Volarevic, Martina; Wu, Catherine H; Smolic, Robert et al. (2007) A novel G418 conjugate results in targeted selection of genetically protected hepatocytes without bystander toxicity. Bioconjug Chem 18:1965-71
Smith, R M; Smolic, R; Volarevic, M et al. (2007) Positional effects and strand preference of RNA interference against hepatitis C virus target sequences. J Viral Hepat 14:194-212
Konishi, Masayoshi; Wu, Catherine H; Kaito, Masahiko et al. (2006) siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations. J Viral Hepat 13:756-61
Virovic, Lucija; Wu, Catherine H; Konishi, Masayoshi et al. (2005) Novel delivery methods for treatment of viral hepatitis: an update. Expert Opin Drug Deliv 2:707-17
Wu, George Y; Konishi, Masayoshi; Walton, Cherie M et al. (2005) A novel immunocompetent rat model of HCV infection and hepatitis. Gastroenterology 128:1416-23
Smith, R M; Wu, G Y (2004) Secondary structure and hybridization accessibility of the hepatitis C virus negative strand RNA 5'-terminus. J Viral Hepat 11:115-23
Fukuma, Toshiko; Walton, Cherie M; Wu, Catherine H et al. (2003) Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression. Bioconjug Chem 14:295-301
Konishi, Masayoshi; Wu, Catherine H; Wu, George Y (2003) Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Hepatology 38:842-50

Showing the most recent 10 out of 43 publications